Status:
COMPLETED
Reduction of Right Ventricular Pacing Using the Feature Ventricular Intrinsic Preference (VIP)
Lead Sponsor:
Abbott Medical Devices
Conditions:
Bradycardia
Eligibility:
All Genders
18-100 years
Phase:
NA
Brief Summary
The purpose of this study is to evaluate the efficacy of the VIP™ feature (available in dual chamber Victory® devices) to reduce unnecessary RV pacing, and to determine if patients with implanted SJM ...
Eligibility Criteria
Inclusion
- Patient has been implanted with dual chamber SJM Victory® device with VIP™ for 1 month (± 2 weeks).
- At the time of pacemaker implant, VIP™ is programmed "OFF".
- At the time of enrollment, patient is paced in the RV ≤ 60% of the time.
- Patient is medically stable.
Exclusion
- Patient has evidence of complete AV block, such that ventricular pacing would be required as part of the patient's routine management.
- Patient is indicated for AF Suppression.
- Patient has persistent or chronic atrial fibrillation.
- Patient is unable to comply with the follow-up visits due to geographical, psychological, or any other reasons.
- Patient is currently participating in another device research study.
- Patient is younger than 18 years of age.
- Patient is pregnant.
- Patients life expectancy is less than 12 months.
Key Trial Info
Start Date :
February 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2008
Estimated Enrollment :
135 Patients enrolled
Trial Details
Trial ID
NCT00311168
Start Date
February 1 2006
End Date
September 1 2008
Last Update
August 12 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Abbott
Sylmar, California, United States, 91342